Clinical Trials Browser

Pancreatic Metastatic Cancer

Borderline Resectable Pancreatic Adenocarcinoma

Colorectal Neoplasms

Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Biliary Tract Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Pancreatic Neoplasms

Esophageal Neoplasms

Neoplasms, Stomach Neoplasms

Colorectal Neoplasms

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Colorectal Neoplasms

Neoplasm Metastasis, Pancreatic Neoplasms

Pancreatic Neoplasms

Esophageal Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Esophageal Neoplasms, Stomach Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Liver Metastases From Colorectal Cancer (mCRC)

Adenocarcinoma Of Esophagus, Neoplasm Metastasis, Stomach Neoplasms

Cholangiocarcinoma

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Gallbladder Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Small Bowel Adenocarcinoma

Locally Advanced Pancreatic Cancer

Biliary Tract Neoplasms, Stomach Neoplasms

Colorectal Neoplasms

Stomach Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Appendiceal Neoplasms, Colorectal Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Peritoneal Neoplasms, Stomach Neoplasms

Colonic Neoplasms

Pancreatic Neoplasms

Biliary Tract Neoplasms, Gastrointestinal Neoplasms

Pancreatic Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Rectal Neoplasms, Colorectal Neoplasms

Pancreatic Adenocarcinoma

Pancreatic cancer, adult, Pancreatic Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Clinical Trials

PAMELA70

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

AndroMETa-CRC

Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)

Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer

An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer

TOGAR

Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

LyRICX

ILUSTRO

Toco-CoR

EDGE-Gastric

A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer

Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread

PROTECT

FRUITFUL

A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

PANCREAS

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

TRIPP-FFX

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

ICARuS

BBOpCo

STOPGAP

ERASE-CRC

VVSHIP

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer

A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer

CANTOR

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

PANC

CEIL

Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer

Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer

Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer